Viewing nowNeurontin Tablet 10 mg (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

MFDS item code 202001763 · Approved 2020.03.13 · Insurance code 643309670
Treatment of moderate to severe Alzheimer's disease
This medicine is used in the treatment of moderate to severe Alzheimer’s disease. Alzheimer’s disease is a condition that accompanies memory decline and cognitive impairment, and this medication helps improve these symptoms and maintain the patient's daily functioning.
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only if a caregiver can periodically check that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient’s tolerability of treatment should be reassessed periodically. This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7) Administer 5mg daily for 7 days. Week 2 (Days 8–14) Administer 10mg daily for 7 days. Week 3 (Days 15–21) Administer 15mg daily for 7 days. From Week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Older adults: Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine to them.
This medicine should not be administered to patients who are allergic to its components. It should also not be used in patients with significantly impaired liver function or severely poor kidney function. Patients with epilepsy or a history of seizures, or those with a predisposition to seizures, should use this medicine with extra caution. Taking this medicine with other medications that have similar effects can increase central nervous system side effects, so they should not be combined. Situations that can alter the acidity of urine should be closely monitored, and patients with uncontrolled heart disease or high blood pressure must use this medicine with caution. This medication may cause side effects such as dizziness, headache, constipation, drowsiness, and hypertension, most of which are mild to moderate. Neuropsychiatric symptoms such as mental confusion, hallucinations, and seizures may also occur rarely. This medicine can interact with other drugs, so healthcare providers should be consulted especially if taking specific muscle relaxants, antipsychotic medications, anticoagulants, etc. Women who are pregnant or may become pregnant should carefully consider the risks and benefits when using this medicine, and breastfeeding women are advised to stop nursing while using it. It is not recommended for children or adolescents under 18 years old, as safety and efficacy have not been established. In case of overdose, central nervous system symptoms or gastrointestinal symptoms may occur, and as there is no specific antidote, suitable treatment at a hospital is required. This medication may affect the patient's reaction time, so caution is needed when driving or operating machinery. Keep out of reach of children and avoid transferring the medication to another container.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This ensures that the efficacy of the medication is well-maintained and can be used safely.
White, rectangular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.